Mmastodon ScienceScience first seen 2 d ago, last 2 d ago, peak #6
AstraZeneca talk highlights computational drug discovery for KRAS G12C
Original: Interesting talk by Michael Bodnarchuk from Astra Zeneca at # CovModDrugDiscov . He talked about the use of computationa
Michael Bodnarchuk of AstraZeneca spoke at the CovModDrugDiscov conference about using computational tools to discover covalent, brain-penetrant KRAS G12C inhibitors. The approach combines covalent chemistry with computational methods to target the KRAS G12C mutation, including drug candidates capable of crossing the blood-brain barrier. Researchers in the drug discovery and chemistry community are sharing notes on the presentation.
Why now: Conference coverage of new computational approaches to targeting KRAS G12C is drawing interest from the drug discovery and chemistry community.
Michael BodnarchukAstraZenecaCovModDrugDiscovKRAS G12C
Evidence
- Interesting talk by Michael Bodnarchuk from Astra Zeneca at # CovModDrugDiscov . He talked about the use of computational tools to discover covalent, brain-penetrant KRAS G12C inhibitors. # CovalentInhibitor # DrugDiscovery # Chemistry # ChemBio # Science · Stephanhacker2@mstdn.science · 2
API: https://socialmediatrends-api.osmike.com/v1/trends/1500506